Precision medicine (PM) is a medical concept that recommends tailoring healthcare by customizing medical decisions, treatments, techniques, or products to a subset of patients rather than using a one-drug-fits-all approach. Diagnostic testing is frequently used in precision medicine to determine appropriate and optimal therapeutics based on a patient's genetic content or other molecular analysis. Although the term 'personalized medicine' is frequently used to represent this idea, it is sometimes misinterpreted to mean that specific therapies may be tailored to each individual.
As the specialty drug pipeline grows and expands, the definition of a specialty drug continues to shift. Specialty drugs are high-priced prescription medications used to treat complex, long-term illnesses such as cancer. Specialty medications may necessitate unique handling and administration (typically injection or infusion).
Title : Liver biopsy handling of Metabolic-Associated Fatty Liver Disease (MAFLD): The children's hospital of eastern Ontario grossing protocol
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Haptoglobin-Related Protein Without Signal Peptide as biomarker of renal salt wasting (HPRWSP) in hyponatremia, hyponatremia-related diseases and as new syndrome in alzheimer’s disease
John K Maesaka, NYU Langone Hospital Long Island, United States
Title : Revolutionizing healthcare and pharma: Artificial intelligence-powered scientific communications and medical writing
Alessandro Gallo, Springer Healthcare, Italy
Title : Enabling knowledge-driven integration and interoperability in intelligent and ethical transformed health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up via biodesign-driven biotech and upgraded biomarketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Integration of nanotechnology into complex treatment of multiple sclerosis
Andrey Belousov, Kharkiv National Medical University, Ukraine
Title : Preparation and characterization of fibers made from PCL/PVP-ChAgG, along with exploring their potential as wound dressings
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Photoremoval of ketoprofen, naproxen and phenazopyridine from pharmaceutical residues in a hospital wastewater treatment plant via Fe3O4-MnO2@rGO nanocomposite
Delia Teresa Sponza, Dokuz Eylul University, Turkey
Title : Combating aluminium chloride-induced alzheimer's in rats: Neuroprotective effects of Nelumbo nucifera and Bergenia ligulate
Nilay Solanki, Ramanbhai Patel College of Pharmacy, India
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets. Discovery of agonists and antagonists of OR51E1, an understudied G Protein-Coupled Receptor
Vladlen Slepak, University of Miami, United States